S. Li

发表

K. Laczika, C. Marosi, D. Fuchs, 2005, Annals of Hematology.

Shawnta S. Friday-Stroud, Earnest Friday, Anna L. Green, 2005, Annals of Hematology.

New trends in peptide receptor radioligands.

P. Angelberger, I. Virgolini, S. Li, 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.

W. Scheithauer, P. Valent, P. Angelberger, 1994, Cancer research.

Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.

P. Angelberger, I. Virgolini, S. Li, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Vasoactive intestinal peptide receptor scintigraphy.

W. Scheithauer, P. Valent, P. Angelberger, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Ibuprofen inhibits pyrogen-dependent expression of VCAM-1 and ICAM-1 on human endothelial cells.

P. Valent, W. Sperr, E. Menzel, 1996, Life sciences.

Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy.

P. Angelberger, S. Li, C. Pirich, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Characterization of 123I‐vascular endothelial growth factor–binding sites expressed on human tumour cells: Possible implication for tumour scintigraphy

P. Valent, P. Angelberger, I. Virgolini, 2001, International journal of cancer.

Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.

W. Schima, P. Angelberger, S. Li, 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Characterization of LDL and VLDL binding sites on human basophils and mast cells.

P. Valent, W. Sperr, P. Angelberger, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Indium-111-labeled low-density lipoprotein binds with higher affinity to the human liver as compared to iodine-123-low-density-labeled lipoprotein.

P. Angelberger, H. Sinzinger, I. Virgolini, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.

I. Virgolini, F. Rauscha, S. Li, 1997, Arteriosclerosis, thrombosis, and vascular biology.

123I-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract.

W. Scheithauer, P. Valent, P. Angelberger, 1996, Nuclear medicine and biology.

Binding of 111In-labeled LDL to platelets of normolipemic volunteers and patients with heterozygous familial hypercholesterolemia.

P. Angelberger, H. Sinzinger, I. Virgolini, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.

W. Pirker, I. Virgolini, S. Li, 1993, British Journal of Cancer.

Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.

W. Pirker, H. Sinzinger, I. Virgolini, 1993, Atherosclerosis.

Binding of 111In-labeled HDL to platelets from normolipemic volunteers and patients with heterozygous familial hypercholesterolemia.

P. Angelberger, H. Sinzinger, I. Virgolini, 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

Effect of prostaglandin E1 on low density lipoprotein apo-B-receptor binding in human, rat and swine liver in vitro.

P. Angelberger, H. Sinzinger, I. Virgolini, 1991, Prostaglandins.

Comparison of different methods for LDL isolation and radioiodination on liver LDL receptor binding in vitro.

P. Angelberger, H. Sinzinger, I. Virgolini, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.

W. Scheithauer, P. Angelberger, I. Virgolini, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Experience with indium-111 and yttrium-90-labeled somatostatin analogs.

P. Angelberger, I. Virgolini, S. Li, 2002, Current pharmaceutical design.

Imaging of Highly Malignant Osteosarcoma with Iodine-123-Vascular Endothelial Growth Factor

P. Angelberger, M. Dominkus, S. Li, 2012, Oncology.

Abstract

K. Laczika, C. Marosi, D. Fuchs, 1984, Veterinary Record.

Effect of irradiation on the prostaglandin system of human hypernephroma cells.

H. Sinzinger, I. Virgolini, S. Li, 1992, Agents and actions. Supplements.

Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.

W. Scheithauer, P. Angelberger, C. Müller, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.

W. Scheithauer, P. Valent, P. Angelberger, 1994, The New England journal of medicine.

New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.

P. Angelberger, B. Niederle, I. Virgolini, 2000, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Comparison of iodine-123 low-density lipoprotein (LDL) and indium-111 LDL binding to mononuclear cells of healthy normolipaemic controls and patients with heterozygous familial hypercholesterolaemia

P. Angelberger, I. Virgolini, G. Lupattelli, 1994, European Journal of Nuclear Medicine.

123I-Vascular Endothelial Growth Factor-165 (123I-VEGF165) Scintigraphyfor Visualisation of Extranodal Marginal Zone B-Cell Lymphoma of theMucosa-Associated Lymphoid Tissue (MALT) Type

S. Li, M. Raderer, B. Kiesewetter, 2013 .

Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.

O. Majdic, P. Valent, C. Sillaber, 1992, The Journal of biological chemistry.

53. 111in-low-density lipoprotein (ldl) binds with higher affinity to the human liver compared with 123i-ldl

P. Angelberger, H. Sinzinger, I. Virgolini, 1992 .

Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.

W. Scheithauer, P. Angelberger, H. Sinzinger, 1993, British Journal of Cancer.